Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL

Christian Hurtz(Palmetto Hematology Oncology), Sarah K. Tasian(Children's Hospital of Philadelphia)

Journal of Clinical Investigation

March 19, 2020

10.1172/jci134424

Cited by 58

Related Papers

BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia

|The Journal of Experimental Medicine|2011|175

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia

|Blood|2016|163

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia

|Leukemia|2024|5